SMILE: First observational prospective cohort study of migraine in primary care in France. Description of methods and study population

Cephalalgia

Volumn 28, Issue 2, 2008, Pages 164-173

  Geraud G ^a   Valade, D ^b   Lanteri Minet M ^c   Radat, F ^d   Lucas, C ^e   Vives, E ^f   Joubert, J M ^g   Mekies, C ^f  

^a CHU RANGUEIL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c PASTEUR HOSPITAL   (France)

^d HÔPITAL PELLEGRIN   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f Salengro Hospital ^*

^g Schwarz Pharma   (France)

Author keywords

Abortive treatments; Coping behaviours; Migraine; Mood disorders; Prophylactic treatments

Indexed keywords

ACETYLSALICYLIC ACID; ERGOTAMINE DERIVATIVE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRIPTAN DERIVATIVE;

ADULT; AGED; ANXIETY; ARTICLE; CONSULTATION; COPE INVENTORY AVOIDANCE SUBSCALE; COPING BEHAVIOR; COPING STRATEGIES QUESTIONNAIRE CATASTROPHIZING SUBSCALE; EMOTION; FEMALE; FRANCE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALADJUSTMENT; MALE; MIGRAINE; MIGRAINE SPECIFIC QUESTIONNAIRE; PERCEIVED STRESS SCALE; PRIMARY MEDICAL CARE; PROPHYLAXIS; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; STRESS;

ACETAMINOPHEN; ADAPTATION, PSYCHOLOGICAL; ADULT; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANXIETY; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; TRYPTAMINES;

EID: 38049174565     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01489.x     Document Type: Article

References (32)

1. Lucas C, Géraud G, Valade D, Chautard MH, Lantéri-Minet M. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache 2006 46 : 715 25.
2. Henry P, Michel P, Brochet B, Dartigues JF, Tison S, Salamon R. A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 1992 12 : 229 37.
3. Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lantéri-Minet M et al. Prevalence and clinical characteristics of migraine in France. Neurology 2002 59 : 232 7.
4. Lucas C, Chaffaut C, Artaz MA, Lantéri-Minet M. FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 2005 25 : 267 79.
5. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994 44 (Suppl. 7 17 22.
6. Merikangas KR, Stevens DE. Comorbidity of migraine and psychiatric disorders. Neurol Clin 1997 15 : 115 23.
7. Sheftell FD, Atlas SJ. Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application. Headache 2002 42 : 934 44.
8. Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2005 25 : 165 78.
9. Devlen J. Anxiety and depression in migraine. J R Soc Med 1994 87 : 338 41.
10. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 : 361 70.
11. Lantéri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 2005 118 : 319 26.
12. Oedegaard KJ, Neckelmann D, Mykletun A, Dahl AA, Zwart JA, Hagen K, Fasmer OB. Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 2006 26 : 1 6.
13. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 1 160.
14. Lépine JP. L'échelle HAD. In : Guelfi JD, editor. L'évaluation clinique standardisée en psychiatrie. Paris : Editions Médicales Pierre Fabre, 1996 : 367 74.
15. Wilkinson MJ, Barczak P. Psychiatric screening in general practice: comparison of the general health questionnaire and the Hospital Anxiety Depression scale. J R Coll Gen Pract 1988 38 : 311 13.
16. Olssøn I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005 5 : 46.
17. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983 24 : 385 96.
18. Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the migraine-specific quality of life questionnaire. Headache 1998 38 : 295 302.
19. Lantéri-Minet M, Pradalier A, Valade D, Vicaut E, Delgado A, Géraud G. Development of a four-item Migraine Specific Quality of life questionnaire (MSQ4) to evaluate the need for a migraine preventive treatment in general practice. Cephalalgia 2005 25 : 940.
20. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 1989 56 : 267 83.
21. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997 4 : 92 100.
22. Muller L, Spitz E. Multidimensional assessment of coping: validation of the Brief COPE among French population. Encephale 2003 29 : 507 18.
23. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 1983 17 : 33 44.
24. Swartzman LC, Gwadry FG, Shapiro AP, Teasell RW. The factor structure of the coping strategies questionnaire. Pain 1994 57 : 311 6.
25. Géraud G, Lantéri-Minet M, Lucas C, Valade D for the French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther 2004 26 : 1305 18.
26. Lantéri-Minet M, Valade D, Géraud G, Chautard MH, Lucas C. Migraine and probable migraine - results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia 2005 25 : 1146 58.
27. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002 58 : 885 94.
28. Kroenke K. Studying symptoms: sampling and measurement issues. Ann Intern Med 2001 134 : 844 53.
29. Fava M, Rankin MA, Wright EC, Alpert JE, Nierenberg AA, Pava J, Rosenbaum JF. Anxiety disorders in major depression. Compr Psychiatry 2000 41 : 97 102.
30. Merikangas KR, Stevens DE. Comorbidity of migraine and psychiatric disorders. Neurol Clin 1997 15 : 115 23.
31. De Diego EV, Lanteri-Minet M. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia 2005 25 : 184 90.
32. Kosinsky M, Bayliss MS, Bjorner JB, Ware JE, Garber WH, Batenhorst A et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003 12 : 963 74.